Nachrichten zur Kimberly-Clark Corp. Aktie

Kimberly-Clark tops quarterly profit estimates on cost cuts, essential products demand

Kimberly-Clark exceeded quarterly profit expectations on Tuesday, helped by cost controls and steady demand for its products including Huggies diapers…

Kimberly-Clark Q4 Earnings Top Estimates, Organic Sales Up 2.1%

KMB beats fourth-quarter estimates as organic sales rose 2.1%, even as revenues dip from exiting its U.S. private-label diaper business.…

ISS recommends shareholders approve Kimberly-Clarks planned Kenvue deal

Institutional Shareholder Services on Friday recommended that ?shareholders approve plans by Kleenex maker Kimberly-Clark ?to buy Tylenol maker Kenvue, saying…

ISS recommends shareholders approve Kimberly-Clark’s planned Kenvue deal By Reuters

ISS recommends shareholders approve Kimberly-Clark’s planned Kenvue deal…

Could Buying Kimberly-Clark Stock Today Set You Up For Life?

The maker of bathroom products is about to undergo a significant change in its business.…

Kimberly-Clark: Buy This Dividend Aristocrat While The Market Overreacts

…

Is KMBs Brand Investment Strategy Enhancing Its Competitive Edge?

Kimberly-Clarks disciplined brand reinvestment is driving sustained volume-plus-mix growth, share gains, and margin expansion despite cost pressures.…

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

…

Is KMBs Powering Care Strategy Building a Competitive Edge Into 2026?

Kimberly-Clarks Powering Care strategy is driving volume-plus-mix growth, stronger innovation cycles and margin ambitions as it heads into 2026.…

KMB vs. PG: Which Consumer Staples Stock Offers Better Upside Now?

Procter & Gambles scale and cash flow strength contrast with Kimberly-Clarks execution-heavy recovery, shaping the upside debate in staples.…

Can Premiumization Keep KMB Growing Ahead of Category Trends?

Kimberly-Clarks Q3 2025 results show premiumization, driving a seventh straight quarter of volume-plus-mix growth despite pressured categories.…

Kimberly-Clark: The Kenvue Deal Could Be Used To Cut The Dividend - Strong Sell

…

Is the Options Market Predicting a Spike in Kimberly-Clark Stock?

Investors need to pay close attention to KMB stock based on the movements in the options market lately.…

Kenvue: Worth Owning As Kimberly-Clark Deal Plays Out

…

The Multibillion-Dollar Battle For Metsera’s Obesity Drugs

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…

Tylenol maker Kenvue secures deal from consumer goods giant

Kimberly-Clark, manufacturer of consumer goods and personal care products, is best known for its paper-based products, including Scott, Cottonelle, Kleenex,…

Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand resilient

Kimberly-Clark CEO Mike Hsu discussed his companys $48.7 billion acquisition of Kenvue in a Monday interview with CNBCs Jim Cramer.…

Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark By Reuters

Factbox-Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark…

Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith By Reuters

Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith…

Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith

Kimberly-Clarks nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the worlds biggest consumer market, the…

Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.…

Why Kimberly-Clark (KMB) Stock Is Nosediving

Shares of household products company Kimberly-Clark (NYSE:KMB) fell 12.6% in the afternoon session after it announced a deal to acquire…

Kimberly-Clark buys out Kenvue in $48.7B consumer health merger

Kimberly-Clark has placed an ambitious bet on a troubled counterpart,…

S&P 500, Nasdaq gain after Amazon-OpenAI deal; Kenvue soars after buyout

The S&P 500 and Nasdaq kicked off November on firmer ground on Monday, after a slew of AI deals boosted…

Kimberly-Clark to buy Tylenol maker Kenvue in massive consumer merger

Caroline Woods: Big brands and big money - Kimberly-Clark is buying Kenvue in a nearly $50 billion cash and stock…

Huggies maker Kimberly-Clark is buying Tylenol maker Kenvue

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the…

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.…

Kimberly-Clark, Starbucks Push Deal Boom Toward $4 Trillion

Dealmakers inked mergers and acquisitions worth more than $80 billion on Monday as they hurtle toward their second best year…

Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant

The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol.…

Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer…

Kimberly-Clark to acquire Kenvue in $48.7 billion deal

Kimberly-Clark said on Monday it will acquire Tylenol maker Kenvue in a deal valued at about $48.7 billion.…

Kimberly-Clark to acquire Tylenol-maker Kenvue in $48.7B deal

Kimberly-Clark Corp (NYSE:KMB, ETR:KMY) announced it will acquire Kenvue (NYSE:KVUE), the maker of Tylenol and other consumer health products, in…

Kimberly-Clark beats quarterly sales estimates as demand holds for household staples

Huggies diaper maker Kimberly-Clark topped analysts estimates for third-quarter sales on Thursday, as inflation-weary consumers gravitated toward its affordable staples.…

Kimberly-Clark Stock Shows Its Strength as Defensive Names Come Back in Focus

Key PointsInitiated position: 79,790 shares added, estimated at approximately $9.92 million as of Q3 2025The position accounts for 1.55% of…

Kimberly-Clark stock hits 52-week low at 124.09 USD By Investing.com

Kimberly-Clark stock hits 52-week low at 124.09 USD…

Kimberly-Clark: Portfolio Realignment Supports Upside Case

…

Kimberly-Clarks Q2 Earnings Top Estimates, 2025 Outlook Raised

KMB beats second-quarter estimates despite sales dip, driven by five-year high volume growth, and raises 2025 outlook.…

Kleenex tissue maker Kimberly-Clarks quarterly sales jump on strong demand

Kimberly-Clark on Friday posted a rise in second-quarter organic sales and beat profit estimates, led by steady demand for products…

Kimberly-Clark (KMB) Expected to Beat Earnings Estimates: Should You Buy?

Kimberly-Clark (KMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

3 High-Yielding Stocks That Investors Can Buy and Forget About

Key PointsThe stocks listed here pay more than 3% in dividends.Their payout ratios are sustainable, and these businesses have strong…

Why Are These 3 High-Yield Dividend King Stocks Near 52-Week Lows While the S&P 500 Just Hit an All-Time High?

The S&P 500 (SNPINDEX: ^GSPC) closed out the first half of the year at an all-time high -- a remarkable…

Kimberly-Clark: Powering Care And Suzano Partnership Essential For Reviving Margins

…

Suzano’s rating outlook revised to positive by S&P after Kimberly-Clark deal By Investing.com

Suzano’s rating outlook revised to positive by S&P after Kimberly-Clark deal…

Suzano und Kimberly-Clark geben Gründung eines globalen Tissue-Unternehmens bekannt, das in über 70 Ländern tätig sein wird

SÃO PAULO--(BUSINESS WIRE)--Suzano, der weltweit größte Zellstoffhersteller, und Kimberly-Clark, ein weltweit führendes Unternehmen der Konsumgüterindustrie, gaben heute die Gründung eines…

dpa-AFX ProFeed